Ros Matthew 4
4 · Cogent Biosciences, Inc. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-04-03+1,900→ 1,900 totalExercise: $10.75From: 2023-04-03Exp: 2033-04-03→ Common Stock (1,900 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.